Pfizer Inc. (PFE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pfizer Inc.

    NYSE: PFE · Real-Time Price · USD
    23.76
    0.16 (0.68%)
    At close: Sep 26, 2025, 3:59 PM
    23.77
    0.04%
    After-hours: Sep 26, 2025, 07:57 PM EDT

    Pfizer Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 8.05B 2.17B 31.4B 22.46B
    Depreciation & Amortization
    		 7.01B 6.29B 5.06B 5.19B
    Stock-Based Compensation
    		 877M 525M 872M 1.18B
    Other Working Capital
    		 -1.08B -8.42B -6.5B 16.5B
    Other Non-Cash Items
    		 1.97B 5.33B 150M -4.76B
    Deferred Income Tax
    		 -2.1B -3.44B -3.76B -4.29B
    Change in Working Capital
    		 -3.07B -2.17B -4.46B 12.8B
    Operating Cash Flow
    		 12.74B 8.7B 29.27B 32.58B
    Capital Expenditures
    		 -2.91B -3.91B -3.24B -2.71B
    Cash Acquisitions
    		 7.04B -43.43B -23B -12M
    Purchase of Investments
    		 -10.31B -31.18B -38.78B -47.61B
    Sales Maturities Of Investments
    		 8.83B 46.42B 45.46B 28.1B
    Other Investing Acitivies
    		 n/a -180M 3.77B -306M
    Investing Cash Flow
    		 2.65B -32.28B -15.78B -22.55B
    Debt Repayment
    		 -7.16B 35.95B -3.52B -1.1B
    Common Stock Repurchased
    		 n/a n/a -2B n/a
    Dividend Paid
    		 -9.51B -9.25B -8.98B -8.73B
    Other Financial Acitivies
    		 -469M -632M -335M 16M
    Financial Cash Flow
    		 -17.14B 26.07B -14.83B -9.82B
    Net Cash Flow
    		 -1.81B 2.45B -1.51B 158M
    Free Cash Flow
    		 9.84B 4.79B 26.03B 29.87B

    Add to Watchlist